286 related articles for article (PubMed ID: 26523972)
1. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.
Tada T; Zhang Y; Koyama T; Tobiume M; Tsunetsugu-Yokota Y; Yamaoka S; Fujita H; Tokunaga K
Nat Med; 2015 Dec; 21(12):1502-7. PubMed ID: 26523972
[TBL] [Abstract][Full Text] [Related]
2. [Identification of an antiviral host transmembrane protein MARCH8].
Tokunaga K
Uirusu; 2015; 65(2):173-178. PubMed ID: 27760915
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
mBio; 2021 Mar; 12(2):. PubMed ID: 33727347
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Envelope Under Attack.
Wei W; Yu XF
Trends Microbiol; 2016 Mar; 24(3):164-166. PubMed ID: 26803378
[TBL] [Abstract][Full Text] [Related]
5. MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.
Zhang Y; Ozono S; Tada T; Tobiume M; Kameoka M; Kishigami S; Fujita H; Tokunaga K
Microbiol Spectr; 2022 Feb; 10(1):e0061821. PubMed ID: 35019698
[TBL] [Abstract][Full Text] [Related]
6. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
7. Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection.
Zhang Y; Tada T; Ozono S; Yao W; Tanaka M; Yamaoka S; Kishigami S; Fujita H; Tokunaga K
J Biol Chem; 2019 Mar; 294(10):3397-3405. PubMed ID: 30630952
[TBL] [Abstract][Full Text] [Related]
8. MARCH8: the tie that binds to viruses.
Tada T; Zhang Y; Fujita H; Tokunaga K
FEBS J; 2022 Jul; 289(13):3642-3654. PubMed ID: 33993615
[TBL] [Abstract][Full Text] [Related]
9. MARCH8 inhibits viral infection by two different mechanisms.
Zhang Y; Tada T; Ozono S; Kishigami S; Fujita H; Tokunaga K
Elife; 2020 Aug; 9():. PubMed ID: 32778221
[TBL] [Abstract][Full Text] [Related]
10. Further Characterization of the Antiviral Transmembrane Protein MARCH8.
Tada T; Zhang Y; Kong D; Tanaka M; Yao W; Kameoka M; Ueno T; Fujita H; Tokunaga K
Cells; 2024 Apr; 13(8):. PubMed ID: 38667313
[TBL] [Abstract][Full Text] [Related]
11. MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells.
Villalón-Letelier F; Brooks AG; Londrigan SL; Reading PC
mBio; 2021 Oct; 12(5):e0148421. PubMed ID: 34517760
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Viral Glycoprotein Targeting by Membrane-associated-RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
bioRxiv; 2021 Jan; ():. PubMed ID: 33532773
[TBL] [Abstract][Full Text] [Related]
13. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
14. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
15. Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.
Wang Q; Su L
mBio; 2019 Aug; 10(4):. PubMed ID: 31431548
[TBL] [Abstract][Full Text] [Related]
16. SERINC5 Can Enhance Proinflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
Pierini V; Gallucci L; Stürzel CM; Kirchhoff F; Fackler OT
J Virol; 2021 Apr; 95(9):. PubMed ID: 33597208
[TBL] [Abstract][Full Text] [Related]
17. Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.
Beitari S; Pan Q; Finzi A; Liang C
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493821
[TBL] [Abstract][Full Text] [Related]
18. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
[TBL] [Abstract][Full Text] [Related]
19. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
[TBL] [Abstract][Full Text] [Related]
20. The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction.
Xu F; Liu X; Zhang D; Zhao F; Fan Z; Hu S; Mei S; Huang Y; Sun H; Wei L; Guo L; Wang J; Cen S; Liang C; Guo F
Hum Gene Ther; 2021 Sep; 32(17-18):936-948. PubMed ID: 33678011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
